<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AMerger_control_filing</id>
	<title>Definition:Merger control filing - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AMerger_control_filing"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Merger_control_filing&amp;action=history"/>
	<updated>2026-05-01T00:20:29Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Merger_control_filing&amp;diff=17721&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Merger_control_filing&amp;diff=17721&amp;oldid=prev"/>
		<updated>2026-03-15T15:36:16Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏛️ &amp;#039;&amp;#039;&amp;#039;Merger control filing&amp;#039;&amp;#039;&amp;#039; is a mandatory or voluntary submission made to a competition or antitrust authority to secure clearance for a proposed transaction that meets specified jurisdictional thresholds, and it plays a critical role in insurance industry [[Definition:Merger and acquisition (M&amp;amp;A) | mergers and acquisitions]] where consolidation can concentrate market power in particular lines of business, distribution channels, or geographic segments. Insurance transactions frequently trigger merger control review not only because of the absolute size of the parties involved but also because insurance markets can be narrowly defined — a combination of two [[Definition:Specialty insurance | specialty insurers]] writing [[Definition:Directors and officers liability insurance (D&amp;amp;O) | directors&amp;#039; and officers&amp;#039; liability]] in a single country, for instance, may raise competitive concerns even if the overall premium volumes seem modest. The requirement to file exists independently of, and in addition to, the [[Definition:Regulatory approval | insurance-specific regulatory approvals]] that supervisors such as the [[Definition:Prudential Regulation Authority (PRA) | PRA]], [[Definition:National Association of Insurance Commissioners (NAIC) | NAIC]] state regulators, or the [[Definition:Monetary Authority of Singapore (MAS) | MAS]] impose on [[Definition:Change of control | changes of control]] at regulated entities.&lt;br /&gt;
&lt;br /&gt;
📑 The filing process begins with an assessment of whether the transaction meets the applicable thresholds in each relevant jurisdiction — typically based on the worldwide and local revenue (or, in the case of insurance, gross [[Definition:Written premium | written premiums]] or asset values) of the merging parties. In the European Union, the European Commission reviews transactions exceeding defined turnover thresholds under the EU Merger Regulation, and for insurance firms, premiums earned within the EU substitute for traditional turnover metrics in the calculation. In the United States, the Hart-Scott-Rodino Act requires a pre-merger notification to the Federal Trade Commission and Department of Justice when transaction size and party size thresholds are met, while state insurance regulators conduct a parallel [[Definition:Form A filing | Form A]] review for acquisitions of domestic insurers. China&amp;#039;s State Administration for Market Regulation applies its own turnover tests under the Anti-Monopoly Law. For large cross-border insurance deals — such as a global [[Definition:Reinsurance | reinsurer]] acquiring a regional [[Definition:Insurance carrier | carrier]] — filings may need to be made simultaneously in a dozen or more jurisdictions, each with its own forms, timelines, information requirements, and substantive competitive assessment standards.&lt;br /&gt;
&lt;br /&gt;
⏳ Overlooking or misjudging merger control obligations can derail an insurance transaction&amp;#039;s timeline and, in extreme cases, the deal itself. Competition authorities have the power to impose conditions — such as requiring divestiture of overlapping [[Definition:Book of business | books of business]], [[Definition:Insurance license | licenses]], or distribution agreements — or to block a transaction outright if they conclude it would substantially lessen competition. In practice, remedies in insurance mergers have included mandated sales of specific product portfolios, restrictions on [[Definition:Exclusive distribution agreement | exclusive distribution]] arrangements, and commitments to maintain separate [[Definition:Brand | brands]] or [[Definition:Underwriting | underwriting]] platforms for a defined period. Deal counsel typically map out the global filing landscape early during the [[Definition:Memorandum of understanding (MOU) | MOU]] or [[Definition:Letter of intent (LOI) | letter of intent]] stage and build sufficient conditionality into the [[Definition:Share purchase agreement (SPA) | SPA]] to accommodate the longest expected regulatory review period. Careful coordination between merger control filings and insurance-specific [[Definition:Change of control | change-of-control]] approvals is essential, as clearance from one authority does not guarantee approval from the other.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Regulatory approval]]&lt;br /&gt;
* [[Definition:Change of control]]&lt;br /&gt;
* [[Definition:Form A filing]]&lt;br /&gt;
* [[Definition:Merger notification form]]&lt;br /&gt;
* [[Definition:Antitrust review]]&lt;br /&gt;
* [[Definition:Share purchase agreement (SPA)]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>